MacroGenics
MGNX
#9393
Rank
NZ$0.15 B
Marketcap
NZ$2.37
Share price
-0.72%
Change (1 day)
-58.85%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.11 Billion

According to MacroGenics's latest financial reports the company has NZ$0.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.20 B-14.73%
2023-12-31$NZ$0.24 B7.89%
2022-12-31$NZ$0.22 B-36.24%
2021-12-31$NZ$0.35 B-14.45%
2020-12-31$NZ$0.41 B19.75%
2019-12-31$NZ$0.34 B-5.42%
2018-12-31$NZ$0.36 B-14.06%
2017-12-31$NZ$0.42 B8.6%
2016-12-31$NZ$0.38 B-15.25%
2015-12-31$NZ$0.45 B195.75%
2014-12-31$NZ$0.15 B61.2%
2013-12-31$NZ$96.03 M-1059.03%
2012-12-31$-NZ$10.02 Million-55.3%
2011-12-31$-NZ$22.41 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Xencor
XNCR
NZ$1.08 B 833.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 138,847.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.85 B 77,371.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$37.14 B 31,923.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.65 B 14,256.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B 35,497.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B 27,660.78%๐Ÿ‡บ๐Ÿ‡ธ USA